SCHEMBL20600367

SCHEMBL20600367

O=C(O)c1cnc2c(-c3cc(Cl)cc(Cl)c3)nccc2c1N1CCOCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ATR Q13535 11/20 0.46
▸ ATRIP Q8WXE1 9/20 0.46
▸ PKM P14618 2/20 0.45
▸ PIK3CA P42336 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ PRKAB2 O43741 1/20 0.40
▸ PRKAG1 P54619 1/20 0.40
▸ PRKAA2 P54646 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40
▸ PRKAG3 Q9UGI9 1/20 0.40
▸ PRKAG2 Q9UGJ0 1/20 0.40
▸ PRKAB1 Q9Y478 1/20 0.40
▸ ACLY P53396 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30824251 1.00 MEN1 (0.47) MEN1KMT2AATRATRIPPKM
SCHEMBL20621797 0.89 ATR (0.46) MEN1KMT2AATRATRIPPKM
SCHEMBL20600198 0.86 PKM (0.65) MEN1KMT2APKMPIK3CAUSP2
SCHEMBL30824206 0.86 PKM (0.65) MEN1KMT2APKMPIK3CAUSP2
SCHEMBL30207742 0.83 PKM (0.47) MEN1KMT2APKMPIK3CAUSP2
SCHEMBL26167969 0.83 PKM (0.47) MEN1KMT2APKMPIK3CAUSP2
SCHEMBL22734642 0.83 MEN1 (0.41) MEN1KMT2AATRATRIPPKM
SCHEMBL30824248 0.81 CNR2 (0.47) MEN1KMT2AATRATRIPPKM
SCHEMBL20600323 0.81 CNR2 (0.47) MEN1KMT2AATRATRIPPKM
SCHEMBL22734593 0.80 MEN1 (0.45) MEN1KMT2AATRATRIPPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615527-B1 NEW AZAQUINOLINE DERIVATIVES ELANCO ANIMAL HEALTH GMBH (DE) 2024-03-06 — — EP disclosed
CN-110770227-B Novel azaquinoline derivatives 拜耳动物保健有限责任公司 2024-03-01 — — CN disclosed
US-11485733-B2 Azaquinoline derivatives BAYER ANIMAL HEALTH GMBH (DE) 2022-11-01 — — US disclosed
US-11485733-B2 Azaquinoline derivatives BAYER ANIMAL HEALTH GMBH (DE) 2022-11-01 — — US disclosed
US-20200131175-A1 NEW AZAQUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-04-30 — — US disclosed
US-20200131175-A1 NEW AZAQUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-04-30 — — US disclosed
EP-3615527-A1 NEW AZAQUINOLINE DERIVATIVES Bayer Animal Health GmbH (DE) 2020-03-04 — — EP disclosed
CN-110770227-A Novel azaquinoline derivatives 拜耳动物保健有限责任公司 2020-02-07 — — CN disclosed
WO-2019002132-A1 NEW AZAQUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-01-03 — — WO disclosed
WO-2019002132-A1 NEW AZAQUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2019-01-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131175-A1 NEW AZAQUINOLINE DERIVATIVES RECQL, H1-5, CHRM1 MEN1 431/4885KMT2A 253/4885ATR 3484/4885
US-11485733-B2 Azaquinoline derivatives RECQL, H1-5, H1-3 MEN1 175/4885KMT2A 309/4885ATR 3784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback